LeanTaaS
Total Raised
$224.44MInvestors Count
6Deal Terms
2Funding, Valuation & Revenue
10 Fundings
LeanTaaS has raised $224.44M over 10 rounds.
LeanTaaS's latest funding round was a Acq - Fin for on June 6, 2022.
Date | Round | Amount | Investors | Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. | Revenue | Sources |
---|---|---|---|---|---|---|
6/6/2022 | Acq - Fin | 2 | ||||
12/10/2020 | Series D | $130M | 13 | |||
6/24/2019 | Series C - II | $40M | 4 | |||
11/13/2018 | Series C | |||||
11/14/2017 | Series B |
Date | 6/6/2022 | 12/10/2020 | 6/24/2019 | 11/13/2018 | 11/14/2017 |
---|---|---|---|---|---|
Round | Acq - Fin | Series D | Series C - II | Series C | Series B |
Amount | $130M | $40M | |||
Investors | |||||
Valuation | |||||
Revenue | |||||
Sources | 2 | 13 | 4 |
LeanTaaS Deal Terms
2 Deal Terms
LeanTaaS's deal structure is available for 2 funding rounds, including their Series B from November 14, 2017.
Round | Series B | Series A |
---|---|---|
Funding Date | ||
Pre-Money Valuation | ||
Post-Money Valuation | ||
Amount Raised | ||
Shares Authorized | ||
Issuance Price | ||
Dividend Rate | ||
Liquidation Preferences | ||
Liquidation Price | ||
Participation | ||
Conversion Price | ||
Anti Dilution | ||
General Voting | ||
Board Voting | ||
Par Value |
Round | Funding Date | Pre-Money Valuation | Post-Money Valuation | Amount Raised | Shares Authorized | Issuance Price | Dividend Rate | Liquidation Preferences | Liquidation Price | Participation | Conversion Price | Anti Dilution | General Voting | Board Voting | Par Value |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Series B | |||||||||||||||
Series A |
LeanTaaS Investors
6 Investors
LeanTaaS has 6 investors. Bain Capital invested in LeanTaaS's Acq - Fin funding round.
First funding | Last Funding | Investor | Rounds | Board Seats | Type | Location |
---|---|---|---|---|---|---|
6/6/2022 | 6/6/2022 | 1 Acq - Fin | Private Equity | Massachusetts | ||
Private Equity | New York | |||||
Corporate Venture | New York | |||||
Diversified Financial Services | New York | |||||
Venture Capital | New York |
First funding | 6/6/2022 | ||||
---|---|---|---|---|---|
Last Funding | 6/6/2022 | ||||
Investor | |||||
Rounds | 1 Acq - Fin | ||||
Board Seats | |||||
Type | Private Equity | Private Equity | Corporate Venture | Diversified Financial Services | Venture Capital |
Location | Massachusetts | New York | New York | New York | New York |
LeanTaaS Acquisitions
1 Acquisition
LeanTaaS acquired 1 company. Their latest acquisition was Hospital IQ on January 10, 2023.
Date | Investment Stage | Companies | Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. | Total Funding | Note | Sources |
---|---|---|---|---|---|---|
1/10/2023 | Series C | $48.93M | Acquired | 28 |
Date | 1/10/2023 |
---|---|
Investment Stage | Series C |
Companies | |
Valuation | |
Total Funding | $48.93M |
Note | Acquired |
Sources | 28 |
Compare LeanTaaS to Competitors
Qventus provides hospitals and health systems. The company offers predefined machine learning (ML) models and software templates. It develops algorithms to analyze hospital data along with operational and clinical metrics. Qventus was formerly known as AnalyticsMD. It was founded in 2012 and is based in Mountain View, California.
healthPrecision focuses on enhancing healthcare delivery through its artificial intelligence (AI)-powered platform, Medical Brain, which operates in the healthcare technology sector. The company offers a clinical decision support system that engages with patients and healthcare providers to identify health risks and care gaps, providing real-time actionable insights to improve health outcomes and prevent unnecessary emergency room visits. Medical Brain serves various healthcare sectors, including chronic disease management, radiology, infectious diseases, and maternal health, by offering evidence-based clinical modules and guidelines. It was founded in 2017 and is based in New York, New York.
Lumeris focuses on value-based care strategies and managed services within the healthcare sector. It offers various services such as population health management, physician alignment, care delivery optimization, network management, and value-based data analytics. It primarily serves health systems and providers looking for clinical and financial outcomes in value-based care arrangements. Lumeris was formerly known as Essence Group Holdings. The company was founded in 2000 and is based in Maryland Heights, Missouri.
MYSPHERA focuses on aiding patient flow in healthcare organizations by utilizing technology. The company offers solutions for complex processes within operating rooms, emergency departments, and other healthcare settings to aid patient care. MYSPHERA primarily serves the healthcare industry, providing location systems (RTLS) for operational workflows and patient management. It was founded in 2012 and is based in Paterna, Spain.
Xevant develops Proactive Business Monitoring (PBM) performance software to assist in converting data into savings opportunities. The software provides data and insights that help healthcare stakeholders solve the access, quality, and cost issues in the healthcare sector. It was founded in 2016 and is based in Lehi, Utah.
Edifecs operates as a healthcare technology company focused on improving healthcare outcomes, reducing costs, and fostering innovation. The company offers solutions for information exchange connectivity, data correlation, and digital health data optimization without using overly technical language or making subjective claims. Edifecs primarily serves the healthcare industry, including care delivery sites and insurance plans. It was founded in 1996 and is based in Bellevue, Washington.
Loading...